70% of COVID mRNA vaccine doses have gone to the richest countries, so South African scientists are copying Moderna’s COVID vaccine
Credit: Afrigen Biologics
Many steps remain before Afrigen’s mRNA vaccine candidate can be distributed to people in Africa and beyond, and it definitely won’t help to curb the pandemic this year. But the WHO hopes that the process of creating it will lay the foundation for a more globally distributed mRNA-vaccine industry. Patrick Arbuthnot, director of gene-therapy research at the University of the Witwatersrand, says, “We were not intimidated, because mRNA synthesis is a fairly generic procedure.” Despite delays in the shipment of raw materials, the team completed this process in ten weeks and sent vials of mRNA to Afrigen in early December.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Long COVID and kids: more research is urgently neededLike adults, children can experience long COVID, but few studies of the condition include young people. That has to change.
続きを読む »
Canada pushes back against GOP support for COVID protests'Everyone's tired of COVID, but these protests...are not the way to get through it.' Canadian PM Trudeau responds to protests in Ottawa over COVID-19 restrictions: 'A few people shouting and waving swastikas does not define who Canadians are.'
続きを読む »
California Votes To Require COVID Paid Sick LeaveThe California Legislature passed a bill Monday requiring many companies to give workers up to two weeks of paid time off if they get sick from the coronavirus. The bill is retroactive to Jan. 1.
続きを読む »
Omicron found in NYC deer raises questions about COVID transmission from animals to humans
続きを読む »